Medtronic Hits New 52-Week High of $102.59, Showcasing Strong Growth

Medtronic Plc has reached a significant milestone by hitting a new 52-week high of USD 102.59 on November 19, 2025. This achievement underscores the company's robust performance in the Pharmaceuticals & Biotechnology sector, where it holds a substantial market capitalization of USD 119,277 million, categorizing it as a large-cap stock.
Over the past year, Medtronic has demonstrated a strong performance, with a notable increase of 20.69%, significantly outperforming the S&P 500, which recorded a gain of 12.28% during the same period. The company maintains a price-to-earnings (P/E) ratio of 21.00, reflecting its valuation relative to earnings, while its dividend yield stands at 3.08%, indicating a commitment to returning value to shareholders.

Additionally, Medtronic's financial health is illustrated by a debt-to-equity ratio of 0.43 and a return on equity of 11.60%, suggesting a balanced approach to leveraging and efficient use of equity. The stock's previous 52-week low was recorded at USD 79.29, highlighting the significant upward movement in its price.